AR014647A1 - Un polipeptido lipl32 de proteina de membrana externa leptoespiral, un polinucleotido aislado, un vector de expresion, una celula huesped, un metodopara producir dicho polipeptido lipl32, uso de dicho polipeptido para la manufactura de un medicamento, un anticuerpo, una composicion farmaceutica, - Google Patents
Un polipeptido lipl32 de proteina de membrana externa leptoespiral, un polinucleotido aislado, un vector de expresion, una celula huesped, un metodopara producir dicho polipeptido lipl32, uso de dicho polipeptido para la manufactura de un medicamento, un anticuerpo, una composicion farmaceutica,Info
- Publication number
- AR014647A1 AR014647A1 ARP990100770A ARP990100770A AR014647A1 AR 014647 A1 AR014647 A1 AR 014647A1 AR P990100770 A ARP990100770 A AR P990100770A AR P990100770 A ARP990100770 A AR P990100770A AR 014647 A1 AR014647 A1 AR 014647A1
- Authority
- AR
- Argentina
- Prior art keywords
- lipl32
- polypeptide
- expression vector
- methodopara
- polinucleotide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000013604 expression vector Substances 0.000 title abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000589902 Leptospira Species 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 206010024238 Leptospirosis Diseases 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 241000589970 Spirochaetales Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920002401 polyacrylamide Polymers 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se provee una preparacion antigénica que contiene a una membrana de proteína externa asociada con las cepas patogénicas de Leptospira. La proteínaha sido designada LipL32 para lipoproteína de Leptospira y debido a que el polipéptido aisladomigra hasta una posicion correspondiente a un pesomolecular de 32kD en un gel de poliacrilamida desnaturalizante. Se proveen polinucleotidos que codifican a LipL32 y anticuerpos que se enlazan a laproteína que son utiles para el diagnostico dela leptospirosis, un vector de expresion, una célula huésped, un método para producir dicho polipéptido LipL32uso de dichos polipéptidos para la manufactura de un medicamento, un anticuerpo , una composicion farmacéutica, métodos de identificaciony deteccion y unequipo util para dicha deteccion. Además, LipL32 puede usarse inmunologicamente como una vacuna para las patologías asociadas con la espiroqueta.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/028,586 US6306623B1 (en) | 1998-02-24 | 1998-02-24 | Leptospiral major outer membrane protein LipL32 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014647A1 true AR014647A1 (es) | 2001-03-28 |
Family
ID=21844269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100770A AR014647A1 (es) | 1998-02-24 | 1999-02-24 | Un polipeptido lipl32 de proteina de membrana externa leptoespiral, un polinucleotido aislado, un vector de expresion, una celula huesped, un metodopara producir dicho polipeptido lipl32, uso de dicho polipeptido para la manufactura de un medicamento, un anticuerpo, una composicion farmaceutica, |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6306623B1 (es) |
| EP (1) | EP1056865A2 (es) |
| JP (1) | JP2002504319A (es) |
| AR (1) | AR014647A1 (es) |
| AU (1) | AU3310399A (es) |
| BR (1) | BR9908234A (es) |
| WO (1) | WO1999042478A2 (es) |
| ZA (1) | ZA991443B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2804685B1 (fr) * | 2000-02-08 | 2004-08-13 | Envt Toulouse | Utilisation d'une proteine de leptospire pour la prevention et/ou le diagnostic et/ou le traitement de la leptospirose animale et/ou humaine |
| AU2001242666A1 (en) * | 2000-02-29 | 2001-09-12 | Roselieb, Markus | Diagnosis of leptospirosis by monoclonal antibody based-antigen detection |
| FR2846658B1 (fr) * | 2002-10-30 | 2007-03-30 | Virbac | Peptides pour la prevention, le diagnostic et le traitement de la leptospirose animale et/ou humaine. |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| FR2953858B1 (fr) | 2009-12-11 | 2013-03-29 | Envt Toulouse | Methode de detection des leptospires pathogenes basee sur le gene rpob |
| GB201015223D0 (en) * | 2010-09-13 | 2010-10-27 | Sec Dep For Environment Food A | Vaccines |
| WO2012066576A2 (en) * | 2010-11-16 | 2012-05-24 | Godavari Biorefineries Limited | Oligonucleotide primer sequences for detection of leptospira |
| EP2931306A1 (en) * | 2012-12-12 | 2015-10-21 | The Regents of the University of California | Methods and compositions of protein antigens for the diagnosis and treatment of leptospirosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904762D0 (en) * | 1989-03-02 | 1989-04-12 | Glaxo Group Ltd | Biological process |
| DE4015911A1 (de) | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| US5643754A (en) | 1994-05-25 | 1997-07-01 | The Regents Of The University Of California | Nucleic acids encoding a leptospira outer membrane protein |
| US5698394A (en) * | 1994-06-01 | 1997-12-16 | Board Of Regents Of The University Of Nebraska | Nucleotide sequences and methods for detection of Serpulina hyodysenteriae |
| US5837263A (en) * | 1995-05-19 | 1998-11-17 | The Regents Of The University Of California | Leptospira membrane proteins |
-
1998
- 1998-02-24 US US09/028,586 patent/US6306623B1/en not_active Expired - Lifetime
-
1999
- 1999-02-23 ZA ZA9901443A patent/ZA991443B/xx unknown
- 1999-02-24 BR BR9908234-9A patent/BR9908234A/pt not_active IP Right Cessation
- 1999-02-24 EP EP99934286A patent/EP1056865A2/en not_active Withdrawn
- 1999-02-24 JP JP2000532430A patent/JP2002504319A/ja not_active Withdrawn
- 1999-02-24 WO PCT/US1999/004040 patent/WO1999042478A2/en not_active Application Discontinuation
- 1999-02-24 AR ARP990100770A patent/AR014647A1/es unknown
- 1999-02-24 AU AU33103/99A patent/AU3310399A/en not_active Abandoned
-
2001
- 2001-08-08 US US09/925,118 patent/US6632434B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1056865A2 (en) | 2000-12-06 |
| US20020127239A1 (en) | 2002-09-12 |
| JP2002504319A (ja) | 2002-02-12 |
| WO1999042478A2 (en) | 1999-08-26 |
| AU3310399A (en) | 1999-09-06 |
| ZA991443B (en) | 1999-10-27 |
| WO1999042478A3 (en) | 1999-09-30 |
| US6306623B1 (en) | 2001-10-23 |
| BR9908234A (pt) | 2000-10-31 |
| US6632434B2 (en) | 2003-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK609985A (da) | Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne | |
| ES2063965T3 (es) | Vacunas para haemophilus influenzae no tipificable. | |
| BR9306984A (pt) | Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo | |
| ATE198754T1 (de) | Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung | |
| NO912369L (no) | Meningokokk-klasse-1-ytre-membranproteinvaksine. | |
| DE69333802T8 (de) | Äusseres membranprotein von haemophilus | |
| ES2139012T3 (es) | Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana. | |
| ATE112687T1 (de) | Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. | |
| KR900009095A (ko) | 합성 항원, 이의 제조방법 및 용도 | |
| DE69735854D1 (de) | Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind | |
| ES2142790T3 (es) | Epitopos antigenicos presentes sobre iga unida a la membrana pero no secretada. | |
| ES539678A0 (es) | Procedimiento para preparar un polipeptido ciclico | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| AR014647A1 (es) | Un polipeptido lipl32 de proteina de membrana externa leptoespiral, un polinucleotido aislado, un vector de expresion, una celula huesped, un metodopara producir dicho polipeptido lipl32, uso de dicho polipeptido para la manufactura de un medicamento, un anticuerpo, una composicion farmaceutica, | |
| ES2194836T3 (es) | Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana. | |
| ES8801376A1 (es) | Un procedimiento para preparar una proteina hibrida | |
| ATE442439T1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| BR0108654A (pt) | Composição imunogênica, polipeptìdeo isolado, vetor de expressão ou um microorganismo vivo recombinante, célula hospedeira, processos para produzir uma composição imunogênica e um polipeptìdeo ou um fragmento imunogênico do mesmo, uso de um polipeptìdeo ou de um polinucleotìdeo que codifica um polipeptìdeo, método para o tratamento de um indivìduo pela imunoprofilaxia ou terapia, anticorpo, agonista ou antagonista ao polipeptìdeo, composto, e, processos para diagnosticar, uma doença ou uma suscetibilidade a uma doença e a presença de câncer colorretal ou uma suscetibilidade ao câncer colorretal, em um indivìduo | |
| ATE109512T1 (de) | Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind. | |
| DE60118359D1 (de) | Humanische pellino-polypeptide | |
| AR004567A1 (es) | Metodos para detectar la infeccion de t.cruzi, en una muestra biologica, un vector de expresion recombinante, un microorganismo modificado, un kit de diagnostico, una composicion farmaceutica, el uso de la composicion farmaceutica para la preparacion de un medicamento para estimular la produccion de anticuerpos que se liguen a t. cruzi. | |
| ATE134874T1 (de) | Synoviale phospholipasen | |
| ATE473755T1 (de) | Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 large t antigen mit einem intakten n terminus | |
| IT1141277B (it) | Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione | |
| DE3886443D1 (de) | Menschliche Rhinoviruspeptide. |